G2
Contact
G2
Contact

Research · Insurtech

Insurtech: capital, debt and M&A in Mexico 2026

Insurtech capital in the region doubled in 2025 and concentrates in life and health, incumbents enter as strategic investors, and no acquisition of a Mexican insurtech has yet been announced.

By Israel Cerda de la Garza ( LinkedIn opens in a new window ) · · 6 min read

This note gathers the public transaction activity we use to place a mandate in insurtech. Every figure carries its source and date. We include no estimates of our own.

Capital raising

USD 199 million of venture capital into Latin American insurtechs in 2025, up 117% from the recent low of USD 92 million in 2024, when Mexico captured 32% of the flows and Brazil 33%. In the first half of 2026, USD 90 million was invested with an average round of USD 8.2 million, and life and health captured 76% of the capital with 26% of the companies (Latam Insurtech Journey, 2025 and 2026).

Crabi, a licensed digital motor insurer, raised USD 13.6 million led by Kaszek and Ignia in June 2025, with 30N, Redwood, Carao, Azuro and Newtopia, in a market where more than 70% of vehicles are uninsured (Bloomberg Línea, June 2025).

Sofía raised USD 13.5 million led by Kfund in December 2024, with Index Ventures, Kaszek and BID Lab, and a further USD 21 million in May 2026, for a total of USD 46 million since 2018 (LatamFintech, December 2024; Sofía, May 2026). The committee now rewards multilatinas: insurtechs operating in a single country are four times more likely to fail.

Debt and structured financing

In insurance, debt does not replace regulatory capital. A licensed insurer is capitalised with venture capital and reinsurance; the sector reported technical reserves of MXN 2.37 trillion and assets under management of MXN 2.4 trillion, 7% of GDP (AMIS, May 2026). We found no debt lines announced by Mexican insurtechs between 2024 and 2026 in sources we could consult. For a digital agency or a technology enabler, the structure is that of a SaaS: financing against recurring commissions.

The end of creditable VAT from 2026 squeezes margins. The 2026 Revenue Law removes the VAT credit on goods and services used to fulfil insurance contracts, with a transition regime and instalment payments; EY estimates motor and major medical premiums could rise between 10% and 20% (EY, October 2025; El Financiero, December 2025).

Mergers and acquisitions

We found no acquisition of a Mexican insurtech announced between 2024 and 2026. The strategic buyer moves through other routes: GNP Seguros and Médica Móvil invested USD 7.8 million in Meddi, a digital health platform with more than 58 hospitals and 5,000 specialists, in March 2026 (LatamList, March 2026).

Asaas acquired the Brazilian digital broker Mutuus in February 2026; terms undisclosed (LatamList, February 2026). Talanx (HDI) closed the purchase of Liberty Seguros in Chile, Colombia and Ecuador in March 2024, within a regional package of about EUR 1.38 billion with EUR 1.7 billion of additional premiums (Talanx, March 2024), the reference for consolidation among the region’s incumbents.

The ecosystem anticipates consolidation. Technology enablers are now 52% of the region’s 576 insurtechs, with 18 specialising in AI agents for claims, fraud and underwriting; Mexico has 150 companies and attracts 42% of foreign insurtechs expanding in the region (Latam Insurtech Journey, July 2026).

Market context

Insurance penetration of 2.95% of GDP in Mexico, against 5% to 6% in the rest of the region and 8% in the OECD; only 23% of the economically active population has life or medical insurance and three of every ten cars are insured (AMIS, May 2026). More than MXN 1 trillion of premiums in 2025, with real growth of 8%, slowing to 4.8% in the first quarter of 2026 (AMIS, May and June 2026). USD 215.1 billion of premiums in Latin America in 2024, with Mexico growing 11.2% in real terms (MAPFRE Economics, November 2025).

G2’s reading for a mandate

The committee first asks who carries the risk. A digital agency or enabler is valued on recurring commission and policy retention; a licensed insurer on loss ratio, regulatory capital and acquisition cost. With capital concentrated in life and health and no Mexican acquisitions on record, the most likely strategic buyer is the incumbent insurer buying operating efficiency or distribution, as GNP did with Meddi, and the end of creditable VAT makes that efficiency more valuable.

Sources